Cargando…

Management of psychotropic medications in adults with intellectual disability: a scoping review

BACKGROUND/OBJECTIVE(S): Psychotropic medications are commonly prescribed among adults with intellectual disability, often in the absence of a psychiatric diagnosis. The aim of this scoping review is to provide an overview of the extent, range, and nature of the available research on medication use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costello, Ashley, Hudson, Eithne, Morrissey, Susan, Sharma, Drona, Kelly, Dervla, Doody, Owen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518601/ https://www.ncbi.nlm.nih.gov/pubmed/36120887 http://dx.doi.org/10.1080/07853890.2022.2121853

Ejemplares similares

Management of psychotropic medications in adults with intellectual disability: a scoping review protocol
por: Costello, Ashley, et al.
Publicado: (2022)

The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review
por: Doody, Owen, et al.
Publicado: (2021)

An update of the reported effects of the COVID-19 pandemic on person with intellectual disability and their carers: a scoping review
por: Keenan, Paul Michael, et al.
Publicado: (2023)

Reasonable adjustments for people with intellectual disability in acute care: a scoping review of the evidence
por: Moloney, Mairead, et al.
Publicado: (2021)

Support staff liaising effectively with professionals for the rational use of psychotropics for behaviours that challenge in adults with intellectual disabilities: Findings from a co-design event
por: Limbu, Bharati, et al.
Publicado: (2022)

De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary
por: Flood, Bernadette
Publicado: (2018)

Editorial: Safety and side effects of psychotropic medications
por: de Filippis, Renato, et al.
Publicado: (2023)

Widespread Genotype-Phenotype Correlations in Intellectual Disability
por: Casanova, Emily L., et al.
Publicado: (2018)

Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022)

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland
por: Lonchampt, Sophie, et al.
Publicado: (2021)

Nature and extent of intellectual disability nursing research in Ireland: a scoping review to inform health and health service research
por: Doody, Owen, et al.
Publicado: (2021)

Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia
por: Song, Menghuan, et al.
Publicado: (2020)

Intellectual disability and COVID-19: A bibliometric review
por: Ying, Jiangbo, et al.
Publicado: (2022)

Salivary oxytocin in autistic patients and in patients with intellectual disability
por: Pichugina, Yulia A., et al.
Publicado: (2022)

Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018)

Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
por: García‐Domínguez, Laura, et al.
Publicado: (2022)

Aberrant Structural and Functional Developmental Trajectories in Children With Intellectual Disability
por: Ma, Xuejin, et al.
Publicado: (2021)

Disruptive Behaviors and Intellectual Disability: Creating a New Script
por: Chan, Melvin Chin-Hao, et al.
Publicado: (2022)

Clinical predictors of psychotropic medication prescription in children with ASD of the ELENA cohort
por: Geoffray, Marie-maude, et al.
Publicado: (2023)

Comorbidity Burden in Adults With Autism Spectrum Disorders and Intellectual Disabilities—A Report From the EFAAR (Frailty Assessment in Ageing Adults With Autism Spectrum and Intellectual Disabilities) Study
por: Miot, Stéphanie, et al.
Publicado: (2019)

A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study
por: Sheehan, Rory, et al.
Publicado: (2019)

A systematic review of the biological, social, and environmental determinants of intellectual disability in children and adolescents
por: Leonard, Helen, et al.
Publicado: (2022)

State of the Field: Differentiating Intellectual Disability From Autism Spectrum Disorder
por: Thurm, Audrey, et al.
Publicado: (2019)

Differences in pragmatic communication skills of adults with intellectual disabilities and dual diagnoses
por: Djordjevic, Mirjana, et al.
Publicado: (2023)

Psychotropic Medication and Substance Use during Pregnancy by Women with Severe Mental Illness
por: Brameld, Kate J., et al.
Publicado: (2017)

The Contributions of Memory and Vocabulary to Non-Verbal Ability Scores in Adolescents with Intellectual Disability
por: Mungkhetklang, Chantanee, et al.
Publicado: (2016)

Intellectual Disability Associated With Pyridoxine-Responsive Epilepsies: The Need to Protect Cognitive Development
por: Hassel, Bjørnar, et al.
Publicado: (2019)

The after-school sedentary behavior status among children and adolescents with intellectual disabilities
por: Yuan, Yaqing, et al.
Publicado: (2022)

Odor hedonic responses in children and young people with profound intellectual and multiple disabilities
por: De Blasio, Catherine, et al.
Publicado: (2023)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

Case series of drug-induced open bite: Extrapyramidal symptoms related to psychotropic medications
por: Watanabe, Motoko, et al.
Publicado: (2023)

Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK
por: Sheehan, Rory, et al.
Publicado: (2019)

Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
por: Dhandapani, Asha, et al.
Publicado: (2021)

«Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability
por: Demily, Caroline, et al.
Publicado: (2016)

A Novel LINS1 Truncating Mutation in Autosomal Recessive Nonsyndromic Intellectual Disability
por: Muthusamy, Babylakshmi, et al.
Publicado: (2020)

Behavioral and Cognitive Interventions With Digital Devices in Subjects With Intellectual Disability: A Systematic Review
por: Torra Moreno, Marta, et al.
Publicado: (2021)

Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review
por: Adams, Danielle, et al.
Publicado: (2023)

Intellectual disabilities teaching for medical students: a scoping review
por: Towson, Georgia, et al.
Publicado: (2023)

From Learning to Memory: What Flies Can Tell Us about Intellectual Disability Treatment
por: Androschuk, Alaura, et al.
Publicado: (2015)

Clinical, Demographic, and Criminal Behavior Characteristics of Patients With Intellectual Disabilities in a Canadian Forensic Program
por: Ray, Ipsita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7pif2fdit8g0t5tftc5eu9lhst